About 10 results found for searched term "AT-101" (0.055 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M1860 | AT-101 | Bcl-2 |
| R-(-)-gossypol acetic acid | ||
| AT-101 (R-(-)-gossypol acetic acid) is a pan small molecule inhibitor of Bcl-2, Bcl-xL, and Mcl-1. | ||
| M13527 | (R)-(-)-Gossypol acetic acid | Bcl-2 |
| AT-101 (acetic acid); (-)-Gossypol acetic acid; (R)-Gossypol acetic acid | ||
| (R)-(-)-Gossypol acetic acid (AT-101 (acetic acid)) is the levorotatory isomer of a natural product Gossypol. | ||
| M14293 | Nevanimibe hydrochloride | Others |
| PD-132301 hydrochloride; ATR101 hydrochloride | ||
| Nevanimibe hydrochloride (PD-132301 hydrochloride) is an orally active and selective acyl-coenzyme A:cholesterol O-acyltransferase 1 (ACAT1) inhibitor with an EC50 of 9 nM. | ||
| M21064 | Bradanicline | Others |
| ATA-101; TC-5619 | ||
| Bradanicline (ATA-101; TC-5619) is a highly selective α7 nicotinic acetylcholine receptor (nAChR) agonist (EC50=17 nM for human α7 nAChR; Ki=1.4 nM). Bradanicline can be used to study cognitive impairment. | ||
| M25429 | Rezafungin acetate | Anti-infection |
| Biafungin acetate; CD101 acetate; SP-3025 acetate | ||
| Rezafungin acetate is a novel echinocandin-based antifungal agent with potent antifungal activity against Candida, Aspergillus and Pneumocystis. | ||
| M28200 | Nevanimibe | Transferase |
| PD-132301; ATR-101 | ||
| Nevanimibe (PD-132301) is an orally active and selective acyl-coenzyme A:cholesterol O-acyltransferase 1 (ACAT1) inhibitor with an EC50 of 9 nM. Nevanimibe inhibits ACAT2 with an EC50 of 368 nM. Nevanimibe induces cell apoptosis and has the potential for adrenocortical cancer. | ||
| M40908 | Fosgonimeton Ammonium | c-Met |
| ATH-1017 Ammonium | ||
| Fosgonimeton Ammonium is a potentially first-in-class HGF/MET modulator that enhances HGF/MET signaling pathway activity, reverses synaptic disconnection and neuronal loss, and can be used in Alzheimer's Disease (AD)-related studies. | ||
| M50210 | Fosgonimeton | c-Met |
| ATH-1017 | ||
| Fosgonimeton is a potentially first-in-class Hepatocyte Growth Factor Receptor (HGF) agonist that enhances HGF/MET signaling pathway activity for Alzheimer's Disease (AD) research. | ||
| M55251 | ATOR-1015 | TNF Receptor |
| ATOR-1015 is a human CTLA-4 x OX40 targeting IgG1 bispecific antibody with enhanced immune activation and tumor-directed activity for improved efficacy and reduced toxicity. ATOR-1015 induces T-cell activation and Treg depletion in vitro. | ||
| M57695 | AT 1015 | Others |
| AT 1015 | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
